NewsRx

Search our medical news database

Bladder Cancer (Diagnostics)

ImmunoCyt Commercialized for Cancer Diagnosis

Published in Cancer Weekly, September 29th, 1997

DiagnoCure Inc., Quebec City, Quebec, Canada, announced that it plans to proceed with commercialization in Canada and in Europe of its product, ImmunoCyt.

Clinical studies were led by Dr. Yves Fradet, DiagnoCure, and a group of Canadian researchers from Quebec, Ontario, and the Atlantic provinces. ImmunoCyt was presented for the first time at the World Congress of the Societe Internationale d'Urologie, held in Montreal, Quebec, Canada, September 7-11, 1997, and attended by some 6,000 urologists and other specialists.

ImmunoCyt is a non-invasive test which permits the detection of superficial bladder cancer at an early stage from a urine sample. The...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook